Supernus Pharmaceuticals Inc Sustainability Reports
Supernus Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. The company's marketed portfolio includes therapies for attention-deficit/hyperactivity disorder, Parkinson's disease, and epilepsy.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300GRM36VBKISYJ58
FIGI: BBG001SFKFF1
5 reports from 2017 to 2025